How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?

被引：70

作者：

Schwartz, M

Roayaie, S

Llovet, J

机构：

[1] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA

[2] Univ Barcelona, Hosp Clin, IDIBAPS,Digest Dis Inst, BCLC Grp,Liver Unit, Barcelona, Spain

[3] Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY USA

来源：

JOURNAL OF HEPATOLOGY | 2005年 / 43卷 / 04期

关键词：

D O I：

10.1016/j.jhep.2005.07.019

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：584 / 589

页数：6

共 33 条

[1] The surgical treatment of bony metastases of the spine and limbs [J].

Böhm, P ;

Huber, J .

JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2002, 84B (04) :521-529

[2] Bisphosphonates in the treatment of skeletal metastases [J].

Conte, P ;

Coleman, R .

SEMINARS IN ONCOLOGY, 2004, 31 (05) :59-63

[3] Percutaneous image-guided radiofrequency ablation of painful metastases involving bone:: A multicenter study [J].

Goetz, MP ;

Callstrom, MR ;

Charboneau, JW ;

Farrell, MA ;

Maus, TP ;

Welch, TJ ;

Wong, GY ;

Sloan, JA ;

Novotny, PJ ;

Petersen, IA ;

Beres, RA ;

Regge, D ;

Capanna, R ;

Saker, MB ;

Grönemeyer, DHW ;

Gevargez, A ;

Ahrar, K ;

Choti, MA ;

de Baere, TJ ;

Rubin, J .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :300-306

[4] Adult living donor liver transplantation for patients with hepatocellular carcinoma -: Extending UNOS priority criteria [J].

Gondolesi, GE ;

Roayaie, S ;

Muñoz, L ;

Kim-Schluger, L ;

Schiano, T ;

Fishbein, TM ;

Emre, S ;

Miller, CM ;

Schwartz, ME .

ANNALS OF SURGERY, 2004, 239 (02) :142-149

[5] Increased cancer risk after liver transplantation: a population-based study [J].

Haagsma, EB ;

Hagens, VE ;

Schaapveld, M ;

van den Berg, AP ;

de Vries, EGE ;

Klompmaker, IJ ;

Slooff, MJH ;

Jansen, PLM .

JOURNAL OF HEPATOLOGY, 2001, 34 (01) :84-91

[6] De novo neoplasia after liver transplantation:: An analysis of risk factors and influence on survival [J].

Herrero, JI ;

Lorenzo, M ;

Quiroga, J ;

Sangro, B ;

Pardo, F ;

Rotellar, F ;

Alvarez-Cienfuegos, J ;

Prieto, J ;

Prieto, J .

LIVER TRANSPLANTATION, 2005, 11 (01) :89-97

[7] HEPATIC RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA [J].

IWATSUKI, S ;

STARZL, TE ;

SHEAHAN, DG ;

YOKOYAMA, I ;

DEMETRIS, AJ ;

TODO, S ;

TZAKIS, AG ;

VANTHIEL, DH ;

CARR, B ;

SELBY, R ;

MADARIAGA, J .

ANNALS OF SURGERY, 1991, 214 (03) :221-229

[8]

Koom Woong Sub, 2002, Taehan Kan Hakhoe Chi, V8, P304

[9] Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy [J].

Leung, TWT ;

Tang, AMY ;

Zee, B ;

Yu, SCH ;

Lai, PBS ;

Lau, WY ;

Johnson, PJ .

CANCER, 2002, 94 (02) :421-427

[10] Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection [J].

Livraghi, T ;

Goldberg, SN ;

Lazzaroni, S ;

Meloni, F ;

Solbiati, L ;

Gazelle, GS .

RADIOLOGY, 1999, 210 (03) :655-661

← 1 2 3 4 →